圣湘生物科技股份有限公司是以自主创新基因技术为核心，集诊断试剂、仪器、第三方医学检验服务为一体的体外诊断整体解决方案提供商。公司致力于成为基因科技普惠者，服务国家精准医疗体系和分级诊疗体系建设，是国家基因检测技术应用示范中心、感染性疾病及肿瘤基因诊断技术国家地方联合工程研究中心、国家级博士后科研工作站单位、国家知识产权示范企业。
国内新冠病毒检测产品最早获批上市的前六家企业之一；
抗疫第一股；科创板上市 新贵 ；
全球分子诊断行业技术标杆；
国内分子诊断行业龙头企业；
新型冠状病毒核酸检测产品国内市场占有率第一；
新冠核酸检测产品服务全球近160个国家和地区；
新冠疫情期间，累计向国内外捐赠价值近1.6亿元抗疫物资。
1. Company introduction
Sansure Biotech Inc. is a provider of in vitro diagnosis solution which is based Ｏn independent innovation of gene technology, integrates diagnostic reagents, instruments and third-party medical testing services. The company is committed to bring benefits to gene technology , serve the construction of national precision medical system and hierarchical diagnosis and treatment system. It is the national gene detection technology application demonstration center, infectious diseases and tumor gene diagnosis technology national local joint engineering research center, National Post Doctoral scientific research workstation unit and National Intellectual Property Demonstration Enterprise.
One of the first six companies that have been approved for listing of novel coronavirus detection products in China;
The first anti epidemic stock; the science and innovation stock board listed "new value";
The global molecular diagnosis industry technology benchmark;
Leading domestic molecular diagnosis industry enterprises;
The market share of Novel Coronavirus nucleic acid detection ranks first.
The novel coronavirus nucleic acid detection products serve nearly 160 countries and regions around the world;
During the period of COVID-19 pandemic, a total of nearly 160 million yuan was donated to domestic and foreign anti epidemic materials.
